News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
GlaxoSmithKline to Launch OTC Weight Loss Drug
June 12, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
British drug maker GlaxoSmithKline PLC said Tuesday its consumer health care unit is launching a Food and Drug Administration-approved over-the-counter version of Roche Holding AG's weight loss product Xenical this week.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
GSK
MORE ON THIS TOPIC
Approvals
GSK, Spero’s oral antibiotic wins first FDA nod for complicated UTI
June 18, 2026
·
2 min read
·
Tristan Manalac
Huntington’s disease
UniQure plans Q3 submission for Huntington’s gene therapy after FDA reverses course—again
June 17, 2026
·
4 min read
·
Heather McKenzie
Podcast
Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more
June 17, 2026
·
2 min read
·
Jef Akst
Vaccines
FDA, Moderna appear aligned on mRNA flu shot heading into adcomm
June 16, 2026
·
3 min read
·
Annalee Armstrong